Biotechnology, Alzheimer’s research, and neuroscience drug development by Acumen Pharmaceuticals
Acumen Pharmaceuticals, Inc. promotes presence as Silver Sponsor at Alzheimer association conference in London
Acumen Pharmaceuticals, Inc. announced its participation as a Silver Sponsor at the Alzheimer Association International Conference in London. The company is inviting conference attendees to ...
Acumen Pharmaceuticals, Inc. commits to advancing targeted therapies for Alzheimer care
Acumen Pharmaceuticals, Inc. is strengthening its commitment to developing targeted treatments for Alzheimer patients and their families. The company reiterated the importance of supporting ...
Acumen Pharmaceuticals, Inc. advances two new Enhanced Brain Delivery candidates for Alzheimer treatment
Acumen Pharmaceuticals, Inc. announced the nomination of two candidates using its Enhanced Brain Delivery technology for development in the treatment of Alzheimer disease, as part of a ...
Acumen Pharmaceuticals, Inc. pushes research for brain health as dementia numbers climb
June marks Alzheimer and Brain Awareness Month, with more than 55 million people worldwide living with dementia, Acumen Pharmaceuticals, Inc. stated. The biopharmaceutical company has reaffirmed ...
Acumen Pharmaceuticals, Inc. posts first quarter financial results and reports business momentum
Acumen Pharmaceuticals, Inc. has released its first quarter financial results along with an update on recent business activities. The company provided further details and performance highlights ...
Research presented by Acumen Pharmaceuticals explores new approach at AAN meeting
Acumen Pharmaceuticals, Inc. unveiled fresh research this week as Chief Medical Officer Eric Siemers, MD, presented a poster at the AAN conference in Chicago. The presentation highlighted the ...
Acumen Pharmaceuticals, Inc. unveils novel antibodies targeting amyloid beta oligomers at ADPD2026
Acumen Pharmaceuticals, Inc. presented new research on the development and characterization of novel antibodies with high selectivity for amyloid beta oligomers at the ADPD2026 conference. The ...
Team members drive company mission, Acumen Pharmaceuticals, Inc. asserts
Acumen Pharmaceuticals, Inc. is emphasizing the importance of its workforce by recognizing standout team members and their impact on the company mission. The company released details about Yuli ...
Acumen Pharmaceuticals celebrates team contributions
Acumen Pharmaceuticals, Inc. is spotlighting the remarkable work and achievements of its team members. The company emphasizes a people-first approach, showcasing the journey and contributions of ...
